Skip to main content

Table 1 Comparison between Gullian Barré patients and control subjects at initial assessment

From: Sleep and psychiatric abnormalities in Gullian Barré Syndrome

  Patients Control ANOVA
  Mean ± SD Mean ± SD f value p value
Overall Disability Sum Score Early 5.95 ± 0.82 0.7 0 ± 0.82 156.47 > 0.0001*
Late 4.15 ± 0.67 > 0.0001*
Neuropathy Pain Scale Early 17.35 ± 8.28 9.0 ± 3.59 10.09 0.004*
Late 9.15 ± 5.02 0.998
Hamilton Anxiety Scale Early 25.9 ± 5.7 7.7 ± 2.16 22.5 > 0.0001*
Late 21.15 ± 5.54 > 0.0001*
MADRS Early 18.9 ± 9.96 7.4 ± 5.08 6.74 0.002*
Late 15.55 ± 7.12 0.033*
Mean sleep latency of MSLT (min) Early 11.79 ± 3.97 16.64 ± 2.2 6.79 0.002*
Late 14.23 ± 3.45 0.185
Total sleep time (hours) Early 5.28 ± 0.43 7.29 ± 0.33 70.49 > 0.0001*
Late 5.64 ± 0.49 > 0.0001*
Wake after sleep onset (hours) Early 2.91 ± 0.588 0.85 ± 0.34 64.66 > 0.0001*
Late 2.53 ± 0.41 > 0.0001*
Sleep efficiency (%) Early 62.56 ± 5.93 86.38 ± 4.22 74.44 > 0.0001*
Late 67.53 ± 4.57 > 0.0001*
SSTI (No of sleep stages/h) Early 21.9 ± 6.51 8.6 ± 1.6 24.5 > 0.0001*
Late 19.74 ± 4.36 > 0.0001*
Apnea hypopnea index (/hour) Early 19.11 ± 7.75 5.67 ± 5.46 16.64 > 0.0001*
Late 18.2 ± 5.15 > 0.0001*
Pulse Transit Time (msec) Early 184.6 ± 23.2 241.4 ± 13.2 13.6 > 0.0001*
Late 232.3 ± 12.3 > 0.0001*
Arousal index (/hour) Early 37.6 5 ± 12.69 5.5 ± 2.63 33.64 > 0.0001*
Late 35.4 ± 10.98 > 0.0001*
Snore Index (/hour) Early 299.3 ± 142.25 29.1 ± 21.89 22.53 > 0.0001*
Late 234.45 ± 81.66 > 0.0001*
Periodic limb movements index (/hour) Early 46.35 ± 22.61 9.9 ± 3.66 13.29 > 0.0001*
Late 41.0 ± 18.92 > 0.0001*
  1. Early after admission and before immunotherapy, Late 1 month after immunotherapy, MADRS Montgomery–Åsberg Depression Rating Scale, MSLT multiple sleep latency test, SSTI sleep stage transition index
  2. *Significant